The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
Background: Cardiovascular autonomic neuropathy (CAN) in type 2 diabetes mellitus (T2DM), which is characterized by lesion of nerve fibers in parasympathetic and sympathetic nervous system is one of the leading causes of heart arrhythmias and an independent risk factor for cardiovascular mortality i...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU |
| Publicado: |
Endocrinology Research Centre
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c7f304c5495742ad8f98f5cc17c006c9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c7f304c5495742ad8f98f5cc17c006c9 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c7f304c5495742ad8f98f5cc17c006c92021-11-14T09:00:22ZThe effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy2072-03512072-037810.14341/DM9630https://doaj.org/article/c7f304c5495742ad8f98f5cc17c006c92019-03-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/9630https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Background: Cardiovascular autonomic neuropathy (CAN) in type 2 diabetes mellitus (T2DM), which is characterized by lesion of nerve fibers in parasympathetic and sympathetic nervous system is one of the leading causes of heart arrhythmias and an independent risk factor for cardiovascular mortality in patients with T2DM. Therefore, the problem of effective treatment of CAN is particularly relevant. Aims: To analyze the effect of long-chain polyunsaturated fatty acids (ω-3 PUFAs) on ambulatory blood pressure monitoring parameters in patients with T2DM and CAN. Materials and methods: 36 patients with T2DM and confirmed CAN were divided into two groups. First group received hypoglycemic therapy (n=15, control) for three months; patients in group 2 (n=21) in addition were administered 1 capsule/q.d. of ω-3 PUFAs for three month. Results: Treatment with ω-3 PUFAs led to significant decrease of the diastolic blood pressure (DBP) (p<0,01), diastolic blood pressure load (p<0,05), time index of DBP (p<0,05) during the day; DBP (p<0,05), diastolic blood pressure load (p<0,05), time index of DBP (p<0,05), SD DBP (p<0,01) during the night (compared to the control group). Conclusions: The study showed that prescription of ω-3 PUFAs for three month was effective in decreasing diastolic blood pressure and its parameters among patients with T2DM and CAN.Victoria A. SerhiyenkoBoris N. MankovskyLudmila М. SerhiyenkoAleksandr A. SerhiyenkoEndocrinology Research Centrearticlediabetic cardiovascular autonomic neuropathypolyunsaturated fatty acidsambulatory blood pressure monitoringNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 22, Iss 1, Pp 62-69 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU |
| topic |
diabetic cardiovascular autonomic neuropathy polyunsaturated fatty acids ambulatory blood pressure monitoring Nutritional diseases. Deficiency diseases RC620-627 |
| spellingShingle |
diabetic cardiovascular autonomic neuropathy polyunsaturated fatty acids ambulatory blood pressure monitoring Nutritional diseases. Deficiency diseases RC620-627 Victoria A. Serhiyenko Boris N. Mankovsky Ludmila М. Serhiyenko Aleksandr A. Serhiyenko The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
| description |
Background: Cardiovascular autonomic neuropathy (CAN) in type 2 diabetes mellitus (T2DM), which is characterized by lesion of nerve fibers in parasympathetic and sympathetic nervous system is one of the leading causes of heart arrhythmias and an independent risk factor for cardiovascular mortality in patients with T2DM. Therefore, the problem of effective treatment of CAN is particularly relevant.
Aims: To analyze the effect of long-chain polyunsaturated fatty acids (ω-3 PUFAs) on ambulatory blood pressure monitoring parameters in patients with T2DM and CAN.
Materials and methods: 36 patients with T2DM and confirmed CAN were divided into two groups. First group received hypoglycemic therapy (n=15, control) for three months; patients in group 2 (n=21) in addition were administered 1 capsule/q.d. of ω-3 PUFAs for three month.
Results: Treatment with ω-3 PUFAs led to significant decrease of the diastolic blood pressure (DBP) (p<0,01), diastolic blood pressure load (p<0,05), time index of DBP (p<0,05) during the day; DBP (p<0,05), diastolic blood pressure load (p<0,05), time index of DBP (p<0,05), SD DBP (p<0,01) during the night (compared to the control group).
Conclusions: The study showed that prescription of ω-3 PUFAs for three month was effective in decreasing diastolic blood pressure and its parameters among patients with T2DM and CAN. |
| format |
article |
| author |
Victoria A. Serhiyenko Boris N. Mankovsky Ludmila М. Serhiyenko Aleksandr A. Serhiyenko |
| author_facet |
Victoria A. Serhiyenko Boris N. Mankovsky Ludmila М. Serhiyenko Aleksandr A. Serhiyenko |
| author_sort |
Victoria A. Serhiyenko |
| title |
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
| title_short |
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
| title_full |
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
| title_fullStr |
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
| title_full_unstemmed |
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
| title_sort |
effect of omega-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy |
| publisher |
Endocrinology Research Centre |
| publishDate |
2019 |
| url |
https://doaj.org/article/c7f304c5495742ad8f98f5cc17c006c9 |
| work_keys_str_mv |
AT victoriaaserhiyenko theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT borisnmankovsky theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT ludmilamserhiyenko theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT aleksandraserhiyenko theeffectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT victoriaaserhiyenko effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT borisnmankovsky effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT ludmilamserhiyenko effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy AT aleksandraserhiyenko effectofomega3polyunsaturatedfattyacidsonambulatorybloodpressuremonitoringparametersinpatientswithtype2diabetesmellitusandcardiovascularautonomicneuropathy |
| _version_ |
1718429489241784320 |